Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/9/2024 | $35.00 | Mkt Perform → Outperform | Barrington Research |
5/6/2024 | $50.00 | Hold → Buy | Lake Street |
2/23/2024 | $60.00 → $40.00 | Buy → Hold | Deutsche Bank |
2/23/2024 | $60.00 → $39.00 | Buy → Hold | Jefferies |
8/3/2022 | $145.00 | Overweight | Stephens |
2/28/2022 | $190.00 → $155.00 | Outperform | Barrington Research |
2/3/2022 | $180.00 → $150.00 | Buy | Deutsche Bank |
12/17/2021 | $180.00 | Buy | Deutsche Bank |
Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Jeff Bennett as Chief Strategy and Innovation Officer and Seth Ravine as Chief Commercial Officer, effective December 2023. "I am incredibly excited for the appointment of these two positions, underscoring our commitment to building a top-notch leadership team that will steer Modivcare's strategic course and drive success in this dynamic landscape," said Heath Sampson, President and CEO of Modivcare. "The addition of Jeff and Seth's roles reinfo
SC 13D/A - ModivCare Inc (0001220754) (Subject)
SC 13D/A - ModivCare Inc (0001220754) (Subject)
SC 13D/A - ModivCare Inc (0001220754) (Subject)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a healthcare services company dedicated to improving member outcomes through an advanced supportive care platform, is pleased to announce Poland resident Payson Priola as Modivcare Maine's Driver of the Year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206655910/en/Payson Priola at Modivcare's Maine office. (Photo: Business Wire) Payson Priola is a non-emergency transportation (NET) driver responsible for transporting Maine Medicaid members between their home and medical appointments, when those individuals have transportation barriers that would otherwise impact
$75 Million in Incremental Term Loan and $30 Million in New Second Lien Notes to Support Operational Improvements, Strategic Priorities and Covenant Relief Will Pursue Strategic Review of Assets with Key Company Advisors to Maximize Value Chief Transformation Officer and Board Additions Bolster Company Leadership Company Withdraws Previously Stated Revenue and Adjusted EBITDA Growth Guidance Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced key initiatives to support future growth. The Company has secured $75 m
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and nine months ended September 30, 2024. Third Quarter 2024 Summary: Service revenue of $702.0 million increased 2.2% from the third quarter of 2023 Net loss of $26.6 million, or negative $1.87 per diluted common share Adjusted EBITDA(1) of $43.2 million, adjusted net income(1) of $6.4 million and adjusted EPS(1) of $0.45 per diluted common share Cash provided by operating activities during the quarter of $9.3 million and
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the third quarter 2024 ended September 30, 2024, on Wednesday, November 6, 2024, after the market closes. Modivcare will host a conference call on Thursday, November 7, 2024, at 8:30 a.m. Eastern Time to discuss third quarter 2024 financial results. The conference call dial-in number for domestic callers is (888) 437-3179, and international callers should dial +1 (862) 298-0702. Interested parties may a
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and six months ended June 30, 2024. Second Quarter 2024 Summary: Service revenue of $698.3 million, remaining consistent with the second quarter of 2023 Net loss of $128.9 million or negative $9.07 per diluted common share Adjusted EBITDA(1) of $45.4 million, adjusted net loss(1) of $0.4 million and adjusted EPS(1) of negative $0.03 per diluted common share Cash used in operating activities during the quarter of $55.3 mil
3 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
3 - ModivCare Inc (0001220754) (Issuer)
8-K - ModivCare Inc (0001220754) (Filer)
DEF 14A - ModivCare Inc (0001220754) (Filer)
PRE 14A - ModivCare Inc (0001220754) (Filer)
Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00
Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00
Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously